Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - April 2014


Clinical Evaluations and Investigations for Medical Devices

08 Apr 2014 - 09 Apr 2014 - Dublin, Ireland



Bookmark and Share


Preparing clinical evaluations and executing clinical investigations in the midst of the revision to MDD have given rise to an increasing challenge to satisfy the demands of Competent Authorities.

This year’s Informa Life Sciences’ Clinical Evaluations and Investigations for Medical Devices conference brings together Competent Authority, Notified Body and top industry experts to examine and interpret the regulatory expectations and to share best practice for preparing Clinical Evaluation Reports, clinical studies and strategies for successful market access and reimbursement.

  • Discover industry best practice for conducting clinical investigations in light of the revision to the Medical Device Directives
  • Hear MHRA feedback on the latest regulatory requirements for evaluations and investigations including: class III medical devices, implantables and combination products
  • Gain first hand feedback, advice and updates on clinical evaluation and investigation requirements from 5 Notified Bodies
  • Benefit from practical insights into carrying out a clinical evaluation
  • Enhanced networking and experience sharing opportunities with 3 new interactive sessions



Further information
Scientific News
Experimental MERS Vaccine Shows Promise in Animal Studies
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques, report National Institutes of Health scientists who designed the vaccines.
Young South African Women can Adhere to Daily PrEP Regimen as HIV Prevention
NIH-funded study finds men in Bangkok, Harlem also successful in taking daily dose.
Researchers Find Key Player in Diabetic Kidney Disease Through Power of Metabolomics
Discovery could lead to new and better diagnostic marker for chronic kidney disease.
Immunotherapy Shows Promise for Myeloma
A strategy, which uses patients’ own immune cells, genetically engineered to target tumors, has shown significant success against multiple myeloma, a cancer of the plasma cells that is largely incurable.
Santhera Announces First Patient Dosing with Omigapil in CMD
Company announces full patient recruitment of CALLISTO study.
Study Shows Promise of Precision Medicine for Most Common Type of Lymphoma
The study appeared online July 20, 2015, in Nature Medicine.
HIV Control Through Treatment Durably Prevents Heterosexual Transmission of Virus
NIH-funded trial proves suppressive antiretroviral therapy for HIV-infected people effective in protecting uninfected partners.
Adaptimmune's Novel Cancer Therapeutics Show Positive Clinical Trial Results
The company has announced that positive data from its Phase I/II study of its affinity enhanced T-cell receptor (TCR) therapeutic targeting the NY-ESO-1 cancer antigen in patients with multiple myeloma has been published.
Early Antiretroviral Therapy Prevents Non-AIDS Outcomes in HIV-infected People
NIH-supported findings illustrate manifold benefit of therapy.
Adaptimmune’s NY-ESO-1 TCR-engineered T-Cells Demonstrate Durable Persistence
Study has been published in Nature Medicine.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!